Chair, Public Good Projects; Former President and CEO, Levi Strauss & Co. and Pepsi-Cola North America
Phil Marineau has an extensive record of success in consumer brand marketing and executive leadership. Most recently, Marineau led Levi Strauss & Co. (LS&CO.) through a successful business turnaround and left an impressive legacy of achievement as its President and Chief Executive Officer. LS&CO. is a leading global apparel company with $4.1 billion sales in more than 110 countries. Marineau, who joined the company in 1999, is credited with restoring LS&CO.’s financial strength and restoring its competitiveness across all dimensions of the business. During his tenure as CEO, shareholder value increased by over 200%.
Prior to joining LS&CO., Marineau was the President and Chief Executive Officer of Pepsi-Cola North America from 1997 to 1999. Under his leadership, Pepsi outgrew Coke in North America for the first time in years, and the Pepsi Bottling Group was spun off into an independent public company.
From 1996 to 1997, Marineau was President and Chief Operating Officer of Dean Foods Company where he oversaw a substantial increase in both sales and earnings. He led the successful repositioning of milk as a beverage, introducing the Chug packaging which revolutionized the dairy business.
Prior to Dean Foods, Marineau was a 23-year veteran of the Quaker Oats Company, where he held progressively responsible positions, including President and Chief Operating Officer from 1993 to 1996. At Quaker, he was responsible for building Gatorade into a multi-billion dollar global brand. As COO, he streamlined Quaker’s go to market practices, making it a recognized leader in efficient consumer response within the packaged goods industry.
Currently, Marineau is a Partner in LNK Partners, a middle market private equity firm which focuses on consumer and retail businesses. He is involved in searching for potential investments as well as providing advice and counsel to companies in LNK’s portfolio.
In addition, Marineau was a member of the Institute of Medicine (part of the National Academies) committee which made comprehensive recommendations on accelerating the fight against obesity in the United States.